Cargando…
Characterisation of the Clinical Pharmacokinetics of Actinomycin D and the Influence of ABCB1 Pharmacogenetic Variation on Actinomycin D Disposition in Children with Cancer
BACKGROUND AND OBJECTIVE: Despite its important role in cancer treatment, there is currently very limited available information concerning the clinical pharmacology of actinomycin D (Act D). The study was designed to characterise Act D pharmacokinetics and investigate the impact of pharmacogenetic v...
Autores principales: | Hill, Christopher R., Cole, Michael, Errington, Julie, Malik, Ghada, Boddy, Alan V., Veal, Gareth J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111883/ https://www.ncbi.nlm.nih.gov/pubmed/24968986 http://dx.doi.org/10.1007/s40262-014-0153-2 |
Ejemplares similares
-
Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo
por: Hill, Christopher R., et al.
Publicado: (2013) -
Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer
por: Walsh, Christopher, et al.
Publicado: (2016) -
ON THE DIFFERENTIAL CYTOTOXICITY OF ACTINOMYCIN D
por: Sawicki, Stanley G., et al.
Publicado: (1971) -
In vitro and in silico evaluations of actinomycin X(2)and actinomycin D as potent anti-tuberculosis agents
por: Qureshi, Kamal Ahmad, et al.
Publicado: (2023) -
Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma
por: Veal, Gareth J., et al.
Publicado: (2016)